Lobbying activity

Q2

TIBER CREEK GROUP for TIBER CREEK HEALTH STRATEGIES, INC. (ON BEHALF OF NOVARTIS)

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $60,000.00 income

Medicare/Medicaid, Health Issues, Trade (domestic/foreign)

View → Q2

ADVANCED POLICY CONSULTING, LLC for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA)

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $40,000.00 income

Health Issues

View → Q2

TODD STRATEGY GROUP for NOVARTIS, INC.

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $60,000.00 income

Health Issues, Medicare/Medicaid, Trade (domestic/foreign)

View → Q2

GSK (FKA GLAXOSMITHKLINE INC.) for GSK (FKA GLAXOSMITHKLINE INC.)

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate

Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid

View → Q2

LUNDBECK LLC for LUNDBECK LLC

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate

Health Issues, Medicare/Medicaid, Trade (domestic/foreign)

View → Q2

HEALTHCARE INSTITUTE OF NEW JERSEY for HEALTHCARE INSTITUTE OF NEW JERSEY

2nd Quarter (Apr 1 - June 30) 2026 · New Jersey · House · Senate

Health Issues

View → Q2

E3 STRATEGIC CONSULTING GROUP for PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION

2nd Quarter (Apr 1 - June 30) 2026 · Virginia · House · Senate · $60,000.00 income

Pharmacy

View → Q2

MARSHALL & POPP, LLC for SANOFI U.S. SERVICES, INC.

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $60,000.00 income

Pharmacy, Copyright/Patent/Trademark, Trade (domestic/foreign), Taxation/Internal Revenue Code

View → Q2

MARSHALL & POPP, LLC for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $40,000.00 income

Pharmacy, Copyright/Patent/Trademark, Trade (domestic/foreign)

View → Q2

MARSHALL & POPP, LLC for PFIZER, INC.

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $60,000.00 income

Pharmacy, Copyright/Patent/Trademark, Trade (domestic/foreign), Taxation/Internal Revenue Code

View → Q2

MARSHALL & POPP, LLC for GENENTECH, INC.

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $60,000.00 income

Pharmacy, Copyright/Patent/Trademark, Trade (domestic/foreign)

View → Q2

MARSHALL & POPP, LLC for AMGEN USA INC.

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $60,000.00 income

Pharmacy, Copyright/Patent/Trademark, Trade (domestic/foreign)

View → Q2

LMH STRATEGIC SOLUTIONS for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $30,000.00 income

Pharmacy, Trade (domestic/foreign)

View → Q2

AEGIS LLC for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $60,000.00 income

Pharmacy, Health Issues

View → Q1

SOLENO THERAPEUTICS, INC. for SOLENO THERAPEUTICS, INC.

1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate

Pharmacy, Trade (domestic/foreign), Financial Institutions/Investments/Securities, Health Issues

View → RR

SOLENO THERAPEUTICS, INC. for SOLENO THERAPEUTICS, INC.

1st Quarter (Jan 1 - Mar 31) 2026 · California

Financial Institutions/Investments/Securities, Health Issues, Medicare/Medicaid, Insurance

View → Q1

GSK (FKA GLAXOSMITHKLINE INC.) for GSK (FKA GLAXOSMITHKLINE INC.)

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate

Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid

View → Q1

NEUROCRINE BIOSCIENCES, INC for NEUROCRINE BIOSCIENCES, INC

1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate

Taxation/Internal Revenue Code, Medicare/Medicaid, Health Issues, Budget/Appropriations

View → Q1

MONUMENT ADVOCACY for PHRMA

1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · $90,000.00 income

Trade (domestic/foreign), Foreign Relations, Health Issues

View → Q1

EMD SERONO, INC. for EMD SERONO INC

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate

Pharmacy, Veterans, Health Issues, Medicare/Medicaid

View → Q1

BIOGEN for BIOGEN

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate

Medicare/Medicaid, Health Issues, Pharmacy, Taxation/Internal Revenue Code

View → Q1

AVENUE SOLUTIONS for GENENTECH USA, INC.

1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate · $50,000.00 income

Medicare/Medicaid, Health Issues

View → Q1

BAYER CORPORATION (CONSOLIDATED REPORT) for BAYER CORPORATION (CONSOLIDATED REPORT)

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate

Copyright/Patent/Trademark, Tariff (miscellaneous tariff bills), Agriculture, Taxation/Internal Revenue Code

View → Q1

THE MCMANUS GROUP for GILEAD SCIENCES, INC.

1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate · $60,000.00 income

Medicare/Medicaid, Health Issues

View → Q1

THE MCMANUS GROUP for GENENTECH

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $50,000.00 income

Medicare/Medicaid, Health Issues, Taxation/Internal Revenue Code

View →